The collaboration includes the initial validation and deployment of Ibex Prostate within HNL Lab Medicine’s LDT workflow.

A new urology lab with advanced diagnostic testing is up and running at UPMC St. Margaret Hospital to deal with a slow but steady increase in the number of prostate cancer cases diagnosed each year.

Prostate cancer affects one in five Australian men, making it the most common cancer in the country. Now, researchers at the ...

If you are diagnosed with early-stage prostate cancer, you usually have three treatment choices: monitoring (called active surveillance), surgery, or radiation therapy. Whole-gland ablation is an ...

Two research teams have developed noninvasive tests that use blood or saliva samples to diagnose cases of colorectal cancer and prostate cancer. The tests, revealed at the 2021 American Association ...

Assistant Professor of Oncology and Cancer Research Immunology, Johns Hopkins University School of Medicine Member, Bloomberg-Kimmel Institute for Cancer Immunotherapy Background: Localized prostate ...

PSA levels can be elevated for reasons other than cancer, such as an enlarged or inflamed prostate. False positive and false negative PSA test results are possible. The American Cancer Society does ...

Facing a prostate cancer diagnosis can feel overwhelming, but you don’t have to navigate it alone. When prostate cancer is caught early, there are several treatment options to consider, and in some ...

As prostate cancer progresses, it becomes increasingly aggressive and can metastasize. In this form, the tumor is difficult to treat, which is reflected in high mortality rates: Worldwide, the ...

Prostate cancer is the most common cancer among men after skin cancer. Age is a significant risk factor for prostate cancer. Family history and genetic factors play a significant role in prostate ...